Study of the uroantiseptic activity of the complex of glycosides of phenolic compounds from lingonberry leaves in complex with the arginine amino acid
DOI:
https://doi.org/10.15587/2519-4852.2023.286462Keywords:
phytosubstance, leaves, lingonberry, uroantiseptic, ratsAbstract
The aim of the work – study the uroantiseptic activity of a complex of glycosides of phenolic compounds from lingonberry leaves in a complex with the amino acid arginine.
Materials and methods. The object of the study was a phytosubstance, which is a complex of glycosides of phenolic compounds from lingonberry leaves in combination with the amino acid arginine (CGPA). Female laboratory rats were given a cleansing enema twice, after which the rats were provided with adequate sedation by injecting IV XYLA 2 % for anesthesia, then rectally injected 1000 μl of Escherichia coli strain at a concentration of 109 CFU/ml. The next day after infection, the animals were subjected to cryogenic action - acute cold stress at a temperature of 0+2 °C for 2.5 hours, promoting the development of the infectious and inflammatory process. The uroantiseptic effect was studied according to the following parameters: the number of leukocytes in the urine, the number of colony-forming microorganisms E.coli in 1 ml of urine (CFU/ml).
Results. According to the obtained results of the experiment, it was established that the complex of glycosides of phenolic compounds from the leaves of lingonberry in a complex with the amino acid arginine (CGPA) showed a high uroantiseptic effect in the experimental treatment of urinary tract infection caused by E. coli ATCC 25922, which was manifested in the sanitation of the urinary tract from the uropathogen E. Coli.
Conclusions. Analyzing the results, it can be concluded that on the model of urinary tract infection against the background of cryogenic exposure, CGPA at a dose of 100 mg/kg showed a uroantiseptic effect, which was stronger than the comparison drug "Inurek" and contributed to a faster disappearance of the titer of colony-forming microorganisms in 1 ml of urine about 2 days earlier than in the group that received dietary supplements of herbal origin "Inurek" and the disappearance of leukocyturia 3 days earlier compared to the group that received therapy with the comparison drug "Inurek". The obtained results indicate the prospects of further research of CGPA with the aim of creating new effective uroantiseptic agents of plant origin based on it
References
- Foxman, B. (2014). Urinary Tract Infection Syndromes. Infectious Disease Clinics of North America, 28 (1), 1–13. doi: https://doi.org/10.1016/j.idc.2013.09.003
- Hryhorenko, V. M., Romashchenko, O. V., Biloholovska, V. V., Volkov, S. S. (2016). Stratehiia likuvannia neuskladnenykh infektsii nyzhnikh sechovyvidnykh shliakhakh. Novyny medytsyny ta farmatsii, 11 (585).
- Malik, R. D., Wu, Y. (Rose), Zimmern, P. E. (2018). Definition of Recurrent Urinary Tract Infections in Women. Female Pelvic Medicine & Reconstructive Surgery, 24 (6), 424–429. doi: https://doi.org/10.1097/spv.0000000000000509
- Geerlings, S. E. (2016). Clinical Presentations and Epidemiology of Urinary Tract Infections. Microbiology Spectrum, 4 (5). doi: https://doi.org/10.1128/microbiolspec.uti-0002-2012
- Wagenlehner, F., Wullt, B., Ballarini, S., Zingg, D., Naber, K. G. (2017). Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert Review of Pharmacoeconomics & Outcomes Research, 18 (1), 107–117. doi: https://doi.org/10.1080/14737167.2017.1359543
- Bonkat, G., Pickard, R., Bartoletti, R. (2018). EAU guidelines on Urological infections. Arnhem, 66.
- Foxman, B. (2014). Urinary Tract Infection Syndromes. Infectious Disease Clinics of North America, 28 (1), 1–13. doi: https://doi.org/10.1016/j.idc.2013.09.003
- Pickard, R., Bartoletti, R. et al. (2016). Guidelines on Urologiсal Infections. European Association of Urology.
- Albert, X., Huertas, I., Pereiro, I., Sanfélix, J., Gosalbes, V., Perrotta, C. (2004). Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database of Systematic Reviews, 3. doi: https://doi.org/10.1002/14651858.cd001209.pub2
- Ivanov, D., Abramov-Sommariva, D., Moritz, K., Eskötter, H., Kostinenko, T., Martynyuk, L. et al. (2015). An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs). Clinical Phytoscience, 1 (1). doi: https://doi.org/10.1186/s40816-015-0008-x
- Eid, H. M., Ouchfoun, M., Brault, A., Vallerand, D., Musallam, L., Arnason, J. T., Haddad, P. S. (2014). Lingonberry (Vaccinium vitis-idaeaL.) Exhibits Antidiabetic Activities in a Mouse Model of Diet-Induced Obesity. Evidence-Based Complementary and Alternative Medicine, 2014, 1–10. doi: https://doi.org/10.1155/2014/645812
- Heyman-Lindén, L., Kotowska, D., Sand, E., Bjursell, M., Plaza, M., Turner, C. et al. (2016). Lingonberries alter the gut microbiota and prevent low-grade inflammation in high-fat diet fed mice. Food & Nutrition Research, 60 (1), 29993. doi: https://doi.org/10.3402/fnr.v60.29993
- Kivimäki, A. S., Ehlers, P. I., Siltari, A., Turpeinen, A. M., Vapaatalo, H., Korpela, R. (2012). Lingonberry, cranberry and blackcurrant juices affect mRNA expressions of inflammatory and atherothrombotic markers of SHR in a long-term treatment. Journal of Functional Foods, 4 (2), 496–503. doi: https://doi.org/10.1016/j.jff.2012.02.010
- Tsemenko, K. V., Kireev, I. V., Komissarenko, M. A., Koshovyi, O. M. (2019). The study of the analgesic activity of the modified extract from Vaccinium vitis-idaea leaves. The Pharma Innovation Journal, 8 (4), 929–931.
- Böger, R. H., Bode-Böger, S. M. (2001). The Clinical Pharmacology of L-Arginine. Annual Review of Pharmacology and Toxicology, 41 (1), 79–99. doi: https://doi.org/10.1146/annurev.pharmtox.41.1.79
- Tsemenko, K. V., Kireiev, I. V., Komisarenko, M. A., Koshovyi, O. M. (2018). Diuretychna aktyvnist fitosubstantsii iz lystia brusnytsi zvychainoi. Aktualni pytannia farmatsevtychnoi i medychnoi nauky ta praktyky, XI (3 (28)), 312–317.
- Tsemenko, K. V., Kyreev, I. V., Osolodchenko, T. P. (2020). Study of the antibacterial activity of new modified galenic and novogalenic phytosubstances from vaccinium vitis-idaea leaves. Annals of Mechnikov Institute, 3, 54–57.
- Roberts, J. A. (1978). Experimental pyelonephritis in the monkey. VI. Infection of infants versus adults. Investigative Urology, 16 (2), 28–30.
- Lukianov, A. V., Dolgikh, V. T., Potievskii, E. G. (2006). Modelirovanie ostrogo pielonefrita u zhivotnykh razlichnogo vida. Biulleten sibirskoi meditciny, 4, 42–47.
- Averianova, N. I., Zvezdakov, V. V., Zimushkina, N. A., Kosareva, P. V., Loginova, I. A., Samodelkin, E. I. (2009). Pat. No. 2349965-2007127373/17. Sposob modelirovaniia ostrogo pielonefrita. declareted: 17.07.2007; published: 20.03.09. Bul. No. 8.
- Yevropeiska konventsiia pro zakhyst khrebetnykh tvaryn, shcho vykorystovuiutsia dlia doslidnykh ta inshykh naukovykh tsilei (1986). Available at: https://zakon.rada.gov.ua/laws/show/994_137
- Horchakova, N. O., Chekman, I. S., Zupanets, I. A. et al.; Stefanova, O. V. (Ed.) (2001). Doklinichni doslidzhennia likarskykh zasobiv. Kyiv: Avitsena, 528.
- Rauf, A., Imran, M., Abu-Izneid, T., Iahtisham-Ul-Haq, Patel, S., Pan, X. et al. (2019). Proanthocyanidins: A comprehensive review. Biomedicine & Pharmacotherapy, 116, 108999. doi: https://doi.org/10.1016/j.biopha.2019.108999
- Babushkina, A. V. (2009). L-arginin s tochki zreniia dokazatelnoi meditciny. Ukrainskii medichnii chasopis, 6, 43–48.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Karyna Tsemenko, Karyna Tolmacheva, Igor Kireyev, Inna Vladymyrova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
